RA
OGN icon

Royce & Associates’s Organon & Co OGN Stock Holding History

Royce & Associates’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Hold
93,576
– – 0.01% 666
2026
Q1 		$561K Buy
93,576
+33,698
+56% +$254K 0.01% 695
2025
Q4 		$429K Buy
59,878
+3,373
+6% +$26.6K ﹤0.01% 719
2025
Q3 		$603K Sell
56,505
-696,419
-92% -$6.83M 0.01% 697
2025
Q2 		$7.29M Sell
752,924
-93,846
-11% -$968K 0.07% 381
2025
Q1 		$12.6M Sell
846,770
-22,624
-3% -$348K 0.14% 229
2024
Q4 		$13M Buy
869,394
+166,300
+24% +$2.71M 0.12% 250
2024
Q3 		$13.5M Buy
703,094
+30,750
+5% +$637K 0.12% 238
2024
Q2 		$13.9M Buy
672,344
+29,278
+5% +$582K 0.13% 225
2024
Q1 		$12.1M Buy
643,066
+14,398
+2% +$247K 0.11% 272
2023
Q4 		$9.07M Buy
628,668
+94,600
+18% +$1.29M 0.08% 339
2023
Q3 		$9.27M Buy
534,068
+169,630
+47% +$3.54M 0.09% 314
2023
Q2 		$7.58M Buy
364,438
+75,083
+26% +$1.63M 0.07% 391
2023
Q1 		$6.81M Sell
289,355
-63,400
-18% -$1.7M 0.07% 416
2022
Q4 		$9.85M Sell
352,755
-11,254
-3% -$288K 0.1% 296
2022
Q3 		$8.52M Sell
364,009
-19,800
-5% -$598K 0.1% 304
2022
Q2 		$13M Sell
383,809
-18,300
-5% -$641K 0.13% 226
2022
Q1 		$14M Sell
402,109
-110,946
-22% -$3.79M 0.12% 259
2021
Q4 		$15.6M Sell
513,055
-7,400
-1% -$241K 0.12% 271
2021
Q3 		$17.1M Sell
520,455
-26,348
-5% -$843K 0.13% 245
2021
Q2 		$16.5M Buy
+546,803
New +$18M 0.11% 311

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Royce & Associates's OGN Position: Q2 2026 in Review

Royce & Associates held its Organon & Co (OGN) position steady in Q2 2026 at 93,576 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #666.

Royce & Associates first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $17.1M in Q3 2021. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Royce & Associates held 93,576 shares of Organon & Co worth $1.27M as of Q2 2026.
  • Royce & Associates left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up 0.01% of Royce & Associates's portfolio in Q2 2026, its #666 holding.
  • Royce & Associates first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Royce & Associates's Organon & Co position peaked at $17.1M in Q3 2021.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.